The hire signals Carl Icahn may be back, at a time when biotech valuations are 25 percent off their 2015 highs. » Read More
By: Dan Mangan
President Donald Trump urged Democrats to work with Republicans in Congress to replace Obamacare, calling it a "disaster." » Read More
By: Jacob Pramuk
Steve Beshear defends the Affordable Care Act in the Democratic response to Trump's address. » Read More
President Trump tells Fox News he plans to use Tuesday night's address to detail ideas on how to fix health care.
Tenet's shares fell more than 11 percent in premarket trading on Tuesday.
Nima is a food-allergen detection device created by MIT graduates to help diners detect dangers on their plates.
The World Health Organization creates the list to spur research for new antibiotics that can counter increasingly resistant bacteria.
Johnson & Johnson said the net increase in the cost of its medicines across its portfolio was 3.5 percent.
The "Fast Money" trader make their case for stocks in the health care sector.
The growth of bacteria in sink drains isn't reassuring when you're expected to wash hands upon entering a hospital, NBC News reports.
A new class of drugs that fight migraines could cost as much as $10,000 a year, NBC News reports.
The death rate from drug overdoses more than doubled between 1999 and 2015, according to a report from the CDC.
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500.
Vice President Mike Pence issued a proclamation to the Conservative Political Action Conference Thursday: the "Obamacare nightmare is about to end."
Opposition to the Affordable Care Act has dropped by seven percentage points since early January, before Donald Trump became president.
A Republican push to repeal and replace Obamacare has slowed amid concerns over large numbers of people losing health coverage.
Shkreli is accused of ripping off his former pharma company Retrophin to pay off hedge-fund investors he was accused of defrauding.
Shares of Bristol-Myers climbed as much as 4 percent after billionaire Carl Icahn reportedly took a stake in the company, according to Dow Jones.
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration.
Get the best of CNBC in your inbox